FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology, and is designed to evaluate the efficacy of organ treatment of early stage metastatic carcinoma of the choroid. To conduct this spectral optical coherence tomography in tumor zone. Evaluate the thickness of the choroid, retinal thickness, the presence or absence of intra- and subretinal fluid. When choroidal thickness 60-180 microns, 33-127 microns thickness of the retina and the lack of intra- and subretinal fluid evaluated as an effective treatment. When choroidal thickness of more than 180 m, the thickness of the retina more than 127 microns, and the presence of intra- and subretinal fluid evaluate treatment as ineffective.
EFFECT: method allows to evaluate the effectiveness of treatment to determine signs of chorioretinal scar formation or for the timely selection and conduct additional treatment.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ASSESSING EFFICIENCY OF COMBINED ORGAN-PRESERVING TREATMENT OF PRIMARY INITIAL RETINOBLASTOMA IN CHILDREN | 2012 |
|
RU2486859C1 |
METHOD OF ESTIMATING EFFICIENCY OF TRANSPUPILLARY THERMOTHERAPY OF INITIAL CHOROIDAL MELANOMA BY METHOD OF SPECTRAL OPTIC COHERENT TOMOGRAPHY | 2011 |
|
RU2458632C1 |
METHOD FOR EARLY DIAGNOSIS OF METASTASES IN CHOROID | 2015 |
|
RU2582751C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF PRIMARY UVEAL MELANOMA AND LOCALIZED CHOROIDAL HEMANGIOMA USING OPTICAL COHERENT TOMOGRAPHY-ANGIOGRAPHY | 2016 |
|
RU2622380C1 |
METHOD FOR DETERMINING INDICATIONS FOR THE REPEATED DESTRUCTION OF THE INITIAL MELANOMA OF CHOROID | 2017 |
|
RU2665185C1 |
METHOD FOR PREDICTING THE COURSE OF THE INITIAL CHOROIDAL MELANOMA | 2017 |
|
RU2645644C1 |
METHOD OF THERAPEUTIC APPROACH SELECTION AT INITIAL STAGE OF RETINOBLASTOMA IN CHILDREN | 2018 |
|
RU2673860C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR VARIOUS FORMS OF PRIMARY INITIAL RETINOBLASTOMA IN CHILDREN | 2012 |
|
RU2479255C1 |
METHOD OF DIAGNOSING INTRAOCULAR NEOPLASMS | 2008 |
|
RU2387378C1 |
METHOD FOR VISUAL FUNCTIONS STATE PREDICTION FOR CHILDREN WITH RETINOBLASTOMA AT BACKGROUND OF SYSTEMIC CHEMOTHERAPY | 2016 |
|
RU2624391C1 |
Authors
Dates
2016-03-10—Published
2014-12-11—Filed